Long-Term Efficacy of Adding Fenofibric Acid to Moderate-Dose Statin Therapy in Patients with Persistent Elevated Triglycerides

Author： Ballantyne Christie   Jones Peter   Kelly Maureen   Setze Carolyn   Lele Aditya   Thakker Kamlesh   Stolzenbach James  

Publisher： Springer Publishing Company

ISSN： 0920-3206

Source： Cardiovascular Drugs and Therapy, Vol.25, Iss.1, 2011-02, pp. : 59-67

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Efficacy and Safety of Fenofibric Acid Co-Administered with Low- or Moderate-Dose Statin in Patients with Mixed Dyslipidemia and Type 2 Diabetes Mellitus: Results of a Pooled Subgroup Analysis from Three Randomized, Controlled, Double-Blind Trials

By Jones Peter H.  

American Journal of Cardiovascular Drugs, Vol. 10, Iss. 2, 2010-04 ,pp. : 73-84

Adis International

Access to resources Recommend Favorite

Year Two Assessment of Fenofibric Acid and Moderate-Dose Statin Combination: A Phase 3, Open-Label, Extension Study

By Kipnes Mark S.  

Clinical Drug Investigation, Vol. 30, Iss. 1, 2010-01 ,pp. : 51-61

Adis International

Access to resources Recommend Favorite

One-Year Efficacy and Safety of Rosuvastatin + Fenofibric Acid Combination Therapy in Patients with Mixed Dyslipidemia: Evaluation of Dose Response

By Ferdinand Keith C.  

American Journal of Cardiovascular Drugs, Vol. 12, Iss. 2, 2012-04 ,pp. : 117-125

Adis International

Access to resources Recommend Favorite

Myalgia in Patients on High‐Dose and Low‐to‐Moderate Dose Statin Therapy

By  

JOURNAL OF PHARMACY PRACTICE AND RESEARCH, Vol. 39, Iss. 3, 2009-09 ,pp. : 202-206

John Wiley & Sons Inc

Access to resources Recommend Favorite

Long-term statin therapy: no negative effects on IMT

By  

Inpharma, Vol. 1, Iss. 1385, 2003-01 ,pp. : 26-26

Adis International

Access to resources Recommend Favorite